Verona Pharma names former Sanofi exec as VP regulatory affairs

UK clinical-stage biopharma firm Verona Pharma (AIM: VRP) today announced the appointment of Desiree Luthman to the company’s executive team as vice president, regulatory affairs.

Dr Luthman’s experience during the last two decades includes a series of roles leading regulatory affairs teams and strategies for pharmaceutical products spanning from early development to post-approval marketing. Throughout her career, she has held regulatory positions at large global pharmaceutical and biotechnology companies, including Bristol-Meyers Squibb, Celgene and AstraZeneca.

Prior to joining Verona Pharma, Dr Luthman directed regulatory activities related to pulmonary disease at Sanofi (Euronext: SAN) and most recently led the French pharma major’s regulatory team through the Food and Drug Administration approval of dupilumab for atopic dermatitis in the USA.